ShareValue scores for DMII: Valuation 37, Quality 50, Growth 50, Health 40.
DMIINASDAQ
Drugs Made In America Acquisition II Corp. Ordinary Shares
$10.11
(0.00%)
DMIINASDAQ
Drugs Made In America Acquisition II Corp. Ordinary Shares
Verdicts
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
Rating
Trap Risk
Return
Company Details
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.